Page last updated: 2024-10-24

candesartan and Glaucoma

candesartan has been researched along with Glaucoma in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"To investigate the neuroprotective effect of candesartan, an angiotensin II type 1 receptor (AT1-R) blocker, against the neurotoxicity of the retinal ganglion cells (RGCs) in an animal model of glaucoma."3.75Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma. ( Fukuda, K; Hirooka, K; Shiraga, F; Yang, H, 2009)
" The angioedema regressed after withdrawal of candesartan, an angiotensin II antagonist that the patient had taken for 1 year."3.72Malignant glaucoma due to drug-related angioedema. ( Hille, A; Hille, K; Ruprecht, KW, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, H1
Hirooka, K1
Fukuda, K1
Shiraga, F1
Hille, K1
Hille, A1
Ruprecht, KW1

Other Studies

2 other studies available for candesartan and Glaucoma

ArticleYear
Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl

2009
Malignant glaucoma due to drug-related angioedema.
    American journal of ophthalmology, 2003, Volume: 135, Issue:2

    Topics: Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Comp

2003